Evidence map›Paper›PMID 41060611›Full record

ReviewCurrent psychiatry reports2025

Psychiatric Considerations in Breast Cancer: an Integrative Review.

Lindsay G Lebin, Katherine C Wu, Olivia Pointer, Erin Baurle

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current psychiatry reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lindsay G LebinDepartment of Psychiatry, Anschutz Medical Campus, University of Colorado School of Medicine, 1890 N Revere Court, MS546, Room 5029, Aurora, 80045, CO, US. Lindsay.lebin@ucdenver.edu.ORCID http://orcid.org/0000-0003-1521-7002
Katherine C WuUVA Health, Department of Psychiatry and Neurobehavioral Sciences, Charlottesville, VA, USA.
Olivia PointerDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Erin BaurleDepartment of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewTo synthesize recent evidence on psychiatric considerations in breast cancer care, focusing on care delivery, psychotherapy, and medication management. RECENT

findingsDistress and psychiatric disorders are common across the breast cancer continuum. Effective care models integrate mental health professionals into oncology settings and leverage telehealth and digital interventions. While multiple psychotherapeutic approaches are beneficial, optimal interventions for specific psychosocial concerns remain unclear. Clinical guidelines caution against combining tamoxifen with strong CYP2D6 inhibitors, though recent evidence challenges the clinical significance of this concern. Benzodiazepines can be used for chemotherapy-related side effects, including nausea and insomnia, though are associated with risk of prolonged use. Psychiatric symptoms are prevalent in breast cancer, impacting health outcomes and quality of life. Routine mental health monitoring and evidence-based psychiatric interventions are integral to care. Further research is needed to refine psychiatric care delivery and optimize interventions across all treatment phases.

Indexed as

Breast NeoplasmsMental DisordersPsychotherapyFemaleHumansBreast cancerMental healthPsychiatric disordersPsychosocial oncology

Identifiers

PMID41060611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.